Marker Therapeutics, Inc.: Form 8-K, filed Feb 9, 2026
Filed with the SEC on Feb 9, 2026 and accepted by EDGAR at Feb 9, 2026, 21:06 ET.
Items reported
- Item 5.08 Item not in the standard list
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001104659-26-012063. Last ingested by Listed: Oct 24, 2026, 15:02 ET. Listed shows no prices and gives no investment advice.